Access cutting-edge copd treatment through this clinical trial at a research site in Tempe. Study-provided care at no cost to qualified participants.
Access copd specialists in Tempe at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd treatment provided free
Subjects who completed either OBERON or TITANIA will be offered the opportunity to consent for this Multicentre, Double-blind, Randomised, Placebo controlled, Parallel Group, Phase 3, extension study to evaluate the safety and efficacy of Tozorakimab in adult participants with symptomatic COPD.
Sponsor: AstraZeneca
Check if you qualify for this copd clinical trial in Tempe, AZ
If you're searching for copd treatment options in Tempe, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tempe research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.